These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12735661

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma.
    Foresi A, Mastropasqua B, Chetta A, D'Ippolito R, Testi R, Olivieri D, Pelucchi A.
    Chest; 2005 Jan; 127(1):117-24. PubMed ID: 15653971
    [Abstract] [Full Text] [Related]

  • 4. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
    Currie GP, Stenback S, Lipworth BJ.
    Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770
    [Abstract] [Full Text] [Related]

  • 5. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]

  • 6. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ, Chervinsky P, Wolfe J, Liddle R, Kellerman DJ, Crescenzi KL.
    J Asthma; 1998 Jul; 35(2):153-64. PubMed ID: 9576141
    [Abstract] [Full Text] [Related]

  • 7. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
    Boulet LP, Turcotte H, Prince P, Lemière C, Olivenstein R, Laprise C, Larivée P, Bégin P, Laviolette M.
    Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
    [Abstract] [Full Text] [Related]

  • 8. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.
    Gershman NH, Wong HH, Liu JT, Fahy JV.
    Eur Respir J; 2000 Jan; 15(1):11-8. PubMed ID: 10678614
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M, Bruce C, Sjöstrand M, Arvidsson P, Lötvall J.
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [Abstract] [Full Text] [Related]

  • 10. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 11. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
    Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
    [Abstract] [Full Text] [Related]

  • 12. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
    Parameswaran K, Inman MD, Watson RM, Morris MM, Efthimiadis A, Ventresca PG, Lam R, O'Byrne PM, Hargreave FE.
    Can Respir J; 2000 Sep; 7(4):313-9. PubMed ID: 10980457
    [Abstract] [Full Text] [Related]

  • 13. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
    Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
    [Abstract] [Full Text] [Related]

  • 14. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Pavord I, Woodcock A, Parker D, Rice L, SOLTA study group.
    Respir Res; 2007 Sep 27; 8(1):67. PubMed ID: 17897478
    [Abstract] [Full Text] [Related]

  • 15. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstätter R.
    Pulm Pharmacol Ther; 2008 Sep 27; 21(2):264-75. PubMed ID: 17604664
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization.
    Di Franco A, Bacci E, Bartoli ML, Cianchetti S, Dente FL, Taccola M, Vagaggini B, Zingoni M, Paggiaro PL.
    Pulm Pharmacol Ther; 2006 Sep 27; 19(5):353-60. PubMed ID: 16289980
    [Abstract] [Full Text] [Related]

  • 18. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 27; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 19. Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma.
    Hofstra WB, Neijens HJ, Duiverman EJ, Kouwenberg JM, Mulder PG, Kuethe MC, Sterk PJ.
    Pediatr Pulmonol; 2000 Jun 27; 29(6):415-23. PubMed ID: 10821721
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.